An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)

This study is ongoing, but not recruiting participants.

Study NCT00608907 Information provided by Millennium Pharmaceuticals, Inc.

First Received: January 23, 2008 Last Updated: February 17, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2010
Estimated Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)